paroxysmal nocturnal haemoglobinuria

paroxysmal nocturnal haemoglobinuria

A rare disease featuring episodic HAEMOLYSIS that occurs during the night when a decline in the pH of the blood triggers activation of complement components. The release of haemoglobin into the blood causes the morning urine to be black. The condition also features thrombosis and this may involve the hepatic vein causing the BUDD-CHIARI SYNDROME.
Mentioned in ?
References in periodicals archive ?
The recommended indication is for the treatment of adult patients with paroxysmal nocturnal haemoglobinuria with haemolysis with clinical symptoms indicative of high disease activity, and also for adult patients who are clinically stable after having been treated with Soliris (eculizumab) for at least the past six months.
Alexion Receives Positive CHMP Opinion for Ultomiris in Adults with Paroxysmal Nocturnal Hemoglobinuria
Whilst I am aware its use is indicated in atypical haemolytic uraemic syndrome, I understood it is a monoclonal antibody targeted against the C5 component of the complement system, and its action on complement is the mechanism of action in this and other disorders, such as paroxysmal nocturnal haemoglobinuria (2).
Shiga-toxigenic Escherichia coli
of Cases % Megaloblastic anaemia 18 23 Acute leukaemia- lymphoblastic 9 11 Myelodysplastic syndrome 6 8 Lymphoma 6 8 Hypoplastic marrow 6 8 Hypersplenism 3 4 Acute leukaemia- myeloid 3 4 Multiple myeloma 3 4 Aplastic anaemia 3 4 Plasmacytosis 2 2 Chronic granulomatous lesion 2 2 Myelofibrosis 2 2 Leukaemia/Lymphoma 1 1 Macrophage activation syndrome 1 1 Marrow necrosis 1 1 Paroxysmal nocturnal haemoglobinuria 1 1 No definite opinion 13 16 Table 2.
PANCYTOPENIA- A CLINICO-HAEMATOLOGICAL STUDY
The product is claimed to be a highly innovative, longer-acting anti-C5 antibody that inhibits terminal complement, which is being evaluated to treat patients with paroxysmal nocturnal haemoglobinuria (PNH).
Alexion Pharmaceuticals receives orphan drug designation for ALXN1210 from US FDA
Richards et al., "The management of pregnancy in paroxysmal nocturnal haemoglobinuria on long term eculizumab," British Journal of Haematology, vol.
Paroxysmal Nocturnal Hemoglobinuria in Pregnancy: A Dilemma in Treatment and Thromboprophylaxis
Paroxysmal nocturnal haemoglobinuria: clinical manifestations, haematology, and nature of the disease.
Cerebral venous thrombosis: a rare presentation of paroxysmal nocturnal hemoglobinuria
John Duggan, 33, was initially refused Soliris by HSE bosses to fight Paroxysmal Nocturnal Haemoglobinuria with which he was diagnosed in 2010.
This is life changing for me.. hopefully now it can be used for others too; Fatal illness man gets miracle drug cure after U-turn on costs
The event at Banney Royd raised cash for treatment of Paroxysmal Nocturnal Haemoglobinuria (PNH) at St James's Hospital, Leeds.
Listed home raises cash for blood conditions
Fujimoto et al., "Establishment of a human T-cell line with deficient surface expression of glycosylphosphatidylinositol (GPI)-anchored proteins from a patient with paroxysmal nocturnal haemoglobinuria," The British Journal of Haematology, vol.
The role of decay accelerating factor in environmentally induced and idiopathic systemic autoimmune disease
[2] Hypercoagulation disorders such as systemic lupus erythematosus, antiphospholipid syndrome, the presence of factor V Leiden, paroxysmal nocturnal haemoglobinuria, hyperhomocysteinaemia, protein C and S deficiency, and heparin-induced thrombocytopenia are also all reported as risk factors for ovarian vein thrombosis.
Ovarian vein thrombosis--a rare but important complication of hysterectomy and oophorectomy
Flow cytometry may be considered to investigate for an abnormal clone in the case of paroxysmal nocturnal haemoglobinuria and may be used on bone marrow samples to further evaluate the cells.
Co-incidental finding of pancytopenia

Medical browser ?
Full browser ?